Europe's drugs regulator has told BBC News it is conducting a review of some weight-loss jabs after being alerted to a possible link to thoughts of suicide and self-harm among users.
Member state Iceland notified the European Medicines Agency after seeing three cases.
The safety assessment will look at Wegovy, Saxenda and similar drugs, such as Ozempic, that help curb appetite.
Product leaflets already list suicidal thoughts as a possible side effect.
An EMA official said: "The review is being carried out in the context of a signal procedure raised by the Icelandic Medicines Agency, following three case reports.
"A signal is information on a new or known adverse event that is potentially caused by a medicine and that warrants further investigation.
"The case reports included two cases of suicidal thoughts - one following the use of Saxenda and one after Ozempic.
"One additional case reported thoughts of self-injury with Saxenda.
"The EMA will communicate further when more information becomes available."
Source: BBC News, 10 July 2023
Recommended Comments
Create an account or sign in to comment